301207 Hualan Biological Vaccine Inc.
- 19.49
- +0.21+1.09%
Hualan Biological Vaccine Inc. News
Hualan Vaccine: Huatai United Securities Co., Ltd.\'s 2024 semi-annual follow-up report on Hualan Biovaccine Co., Ltd.
Hualan Vaccine: Announcement of Board Resolutions
Hualan Vaccine: Special Report on the Storage and Use of Raised Funds for the 2024 Semi-Annual Period
Hualan Vaccine: Announcement of Supervisory Committee Resolutions
Hualan Biological Vaccine Inc.: Company bylaws (July 2024)
Hualan Biological Vaccine Inc.: Statement and Commitment from Independent Director Nominee (Zhang Jinkang)
Hualan Biological Vaccine Inc.: Statement and commitment of the independent director candidate (Zhang Jingang).
Hualan Biological Vaccine Inc.: Announcement of the Resolution of the 8th Meeting of the Second Board of Directors.
Hualan Biological Vaccine Inc.: Announcement of the Resolution of the Seventh Meeting of the Second Board of Supervisors.
Hualan Biological Vaccine Inc.: Announcement of Resolutions of the 7th Meeting of the Second Board of Directors
Hualan Biological Vaccine Inc.: Announcement of Resolutions of the Sixth Meeting of the Second Board of Directors
Hualan Biological Vaccine Inc.: Announcement of Resolutions of the Sixth Meeting of the Second Board of Supervisors
Hualan Vaccine: Huatai United Securities Co., Ltd.'s 2023 follow-up report on Hualan Biovaccine Co., Ltd.
Hualan Vaccine: Announcement on holding the 2023 Online Results Briefing
Hualan Vaccine: 2023 Independent Director's Annual Debriefing Report (Li Dexin)
Hualan Vaccine: Shareholders\' Meeting Rules of Procedure (March 2024)
Hualan Vaccine: 2023 Independent Director\'s Annual Debriefing Report (Dong Guanmu)
Hualan Vaccine: Special Explanation on Capital Utilization by Controlling Shareholders and Other Related Parties
Hualan Vaccine: Huatai United Securities Co., Ltd.\'s inspection opinion on Hualan Biovaccine Co., Ltd.\'s use of its own funds to entrust financial management
Hualan Vaccine: The Board\'s Special Opinion on the Sole Director\'s Independence Assessment
Analysis
Price Target
No Data
No Data